Table of Contents
<< Previous Issue | Jul 2005 (Vol: 2005, Issue: 61) | Next Issue >> |
- Section: Business Commentaries
-
Don't Make Your Drug Deals Poison Pills
- Section: Deal Trackers
-
Dacogen (decitabine)
- Section: Features
-
Serono Continues its Deal Making Spree through Collaborations with BioMarin and NovImmune
-
Anadys Lands Lucrative HCV Deal with Novartis
-
Royalty Rates Used in Pharmaceutical Agreements
-
Therapy Focus: Cystic Fibrosis
- Section: General
-
Renovis and Pfizer Enter Substantial Agreement
-
Vectura Group plc
- Section: Licensing
-
Merck Obtains License from BioXell to Develop TREM-1 Products
-
Cephalon Acquires Cancer Drug Trisenox® from Cell Therapeutics
- Section: Mergers & Acquisitions
-
Pfizer Broadens Anti-Infectives Business through Acquisition of Vicuron
- Section: Research & Development
-
Novartis and Hybridon to Develop Oligonucleotides for Asthma and Allergy
-
Exelixis and Genentech Forge R&D Pact